Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Is Trending Stock SkyWest, Inc. (SKYW) a Buy Now?
Is Trending Stock SkyWest, Inc. (SKYW) a Buy Now?

SkyWest (SKYW) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the

SkyWest (SKYW) Outperforms Broader Market: What You Need to Know
SkyWest (SKYW) Outperforms Broader Market: What You Need to Know

SkyWest (SKYW) closed at $93.70 in the latest trading session, marking a +2.04% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of 0.72%. At the same time

SkyWater Technology, Inc. (SKYT) Stock Slides as Market Rises: Facts to Know Before You Trade
SkyWater Technology, Inc. (SKYT) Stock Slides as Market Rises: Facts to Know Before You Trade

SkyWater Technology, Inc. (SKYT) ended the recent trading session at $28.07, demonstrating a -1.65% change from the preceding day's closing price. The stock's performance was behind the S&P 500's

Why SkyWest (SKYW) Outpaced the Stock Market Today
Why SkyWest (SKYW) Outpaced the Stock Market Today

SkyWest (SKYW) closed the most recent trading day at $95.15, moving +2.72% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 2.51%. Meanwhile, the Dow

SkyWater Technology, Inc. (SKYT) Is a Trending Stock: Facts to Know Before Betting on It
SkyWater Technology, Inc. (SKYT) Is a Trending Stock: Facts to Know Before Betting on It

SkyWater Technology, Inc. (SKYT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the

SKYW Stock Down 8.3% in Six Months: Will the Plunge Last Throughout 2026?
SKYW Stock Down 8.3% in Six Months: Will the Plunge Last Throughout 2026?

SkyWest, Inc.’s SKYW shares had an unimpressive run over the past six months. Shares of the company have plunged 8.3% in the same period, underperforming the Transportation - Airline industry’s 2%

Is It Worth Investing in SkyWest (SKYW) Based on Wall Street's Bullish Views?
Is It Worth Investing in SkyWest (SKYW) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Do Options Traders Know Something About Skyworks Stock We Don't?
Do Options Traders Know Something About Skyworks Stock We Don't?

Investors in Skyworks Solutions, Inc. SWKS need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $27.50 Call had some of the highest

Paramount Skydance Close to Securing $24 Billion for WBD Deal
Paramount Skydance Close to Securing $24 Billion for WBD Deal

Paramount Skydance Corporation PSKY is advancing plans to secure nearly $24 billion in equity commitments from three major Middle Eastern sovereign wealth funds, a move that could significantly

Why Skyward (SKWD) is Poised to Beat Earnings Estimates Again
Why Skyward (SKWD) is Poised to Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Skyward Specialty Insurance (SKWD)

Warner Bros. Discovery Aktie: DOJ verschärft Prüfung
Warner Bros. Discovery Aktie: DOJ verschärft Prüfung

Die geplante Übernahme von Warner Bros. Discovery durch Paramount Skydance für rund 110 Milliarden…

Der Beitrag Warner Bros. Discovery Aktie: DOJ verschärft Prüfung erschien zuerst auf kapitalmarkte

How Will Skyrizi and Rinvoq Shape AbbVie's Q1 Immunology Sales?
How Will Skyrizi and Rinvoq Shape AbbVie's Q1 Immunology Sales?

AbbVie ABBV is set to report first-quarter 2026 results on April 29, with investor focus likely to remain on its immunology segment. Following the loss of exclusivity (LoE) for its flagship drug

Coherent Soars 379% in a Year: Buy, Sell, or Hold the Stock?
Coherent Soars 379% in a Year: Buy, Sell, or Hold the Stock?

Coherent Corp.’s COHR stock has skyrocketed 379.3% over the past year, outperforming the industry's 29.4% growth and the Zacks S&P 500 Composite’s 35.6% rally.

1-Year Share Price Performance

 

Image

Celestica Stock Rises 262.3% in the Past Year: How to Play the Stock
Celestica Stock Rises 262.3% in the Past Year: How to Play the Stock

Celestica, Inc. CLS shares have skyrocketed 262.3% in the past year compared with the Electronics - Manufacturing Services industry’s growth of 133.3%. The stock has outperformed the Zacks Computer

DAVE Stock Skyrockets 116% in a Year: How Should You Play It?
DAVE Stock Skyrockets 116% in a Year: How Should You Play It?

Dave Inc. DAVE stock has registered explosive growth of 116.2% over the past year, outperforming the industry's 28.3% rally and the Zacks S&P 500 composite's 30.8% growth.

1-Year Share Price

Why Skyward Specialty Insurance (SKWD) is a Top Momentum Stock for the Long-Term
Why Skyward Specialty Insurance (SKWD) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different